bioRASI

Biorasi joins GPhA Biosimilar Council

Wednesday, September 7, 2016

Biorasi, a CRO that optimizes trial design and delivery for sponsor organizations, is now an associate member organization of the Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA). This newly minted alliance provides Biorasi with the opportunity to work with the world’s leading-edge biosimilar developers, helping to influence policies, form best practices, and promote science-based research and findings related to biosimilar drugs. 

[Read More]

Biorasi adds endocrinology division, to hire 30

Thursday, February 12, 2015

Biorasi, a full-service CRO powered by ProAct+, has formed an endocrinology division established to consolidate and expand Biorasi market leadership in running clinical trials in diabetes and women’s health. The new division will be led by Bill Doyle, the division manager, out of the Miami, Fla. headquarters.

[Read More]